Our newsletter, the Astria Connection: HAE, is for those impacted by HAE. View our most recent newsletters here to learn more about navenibart (STAR-0215) in clinical development for HAE, our goals, and Astria’s commitment to HAE.
Issue #13 August 2024
Introducing…Navenibart!
Issue #12 July 2024
hae day :-) 2024
Issue #11 March 2024
EXCITING NEWS: Positive Initial Proof-of-Concept Results from the ALPHA-STAR Phase 1b/2 Trial of STAR-0215 for HAE
Issue #10 November 2023
New STAR-0215 Phase 1a Data
Issue #9 August 2023
HAEA National Summit 2023
Issue #8 May 2023
hae day :-) 2023
Issue #7 February 2023
Introducing …The ALPHA-STAR Trial!
Issue #6 December 2022
Exciting Results from Our Phase 1a Trial: What’s Next for STAR-0215
Issue #5 November 2022
“Together Again” at HAEi’s Global Leadership Workshop
Issue #4 August 2022
Investigational Treatments: How Do They Get from the Lab to the Pharmacy
SUBSCRIBE TO OUR NEWSLETTERS
The Astria Connection: HAE
The Astria Connection: AD
ALPHA-STAR Trial
Patient Stories
Newsletters
Resources
About HAE
Navenibart (STAR-0215)
About Atopic Dermatitis
STAR-0310
Scientific Presentations and Publications
Mission & Values
Join Us
Our Team
DE&I
Corporate Responsibility